Keyphrases
Israel
100%
Israeli
24%
Confidence Interval
20%
COVID-19
18%
Hospitalization
18%
Wheezing
16%
Bivalent Oral Poliovirus Vaccine (bOPV)
14%
Wild Poliovirus
13%
Pediatric
12%
Relative Risk
11%
Risk Factors
11%
Periodic Fever
10%
Adenitis
10%
Pharyngitis
10%
Hypertonic Saline
10%
Kawasaki Disease
10%
Aphthous Stomatitis
10%
Bartonella Quintana
10%
Poliovirus Type 1
10%
Epidemiology
10%
Fever
10%
Influenza
9%
Vaccination
8%
Emergency Department
8%
Medical Center
8%
Vaccination Campaign
8%
Public Health Response
8%
Endocarditis
8%
Q Fever
8%
Pediatric Population
7%
Autoimmune Disease
7%
Environmental Surveillance
7%
C-reactive Protein
7%
Neonate
7%
Child Hospitalized
7%
Staphylococcus Aureus
7%
Hospitalization Rate
7%
Pediatric Patients
7%
Incidence Rate
6%
Disease Severity
6%
Serious Bacterial Infection
6%
Atopy
6%
Single Center
6%
Empirical Therapy
6%
High Risk
6%
Hospitalized children
6%
Pneumonia
6%
Intravenous Immunoglobulin (IVIg)
6%
Natural History
6%
Israeli children
6%
Medicine and Dentistry
Pediatrics
29%
COVID-19
16%
Wheeze
14%
Emergency Department
12%
Public Health
12%
Human Poliovirus 1
12%
Infection
12%
Q Fever
10%
Poliomyelitis Virus
10%
Kawasaki Disease
10%
Oral Poliomyelitis Vaccine
10%
Childbirth
10%
Cohort Effect
9%
Disease
8%
Poliomyelitis Vaccine
8%
Cohort Analysis
6%
Disease Severity
6%
Immunoglobulin
5%
Sputum
5%
Epidural Abscess
5%
Periodic Fever, Aphthous Stomatitis, Pharyngitis and Adenitis
5%
Infective Endocarditis
5%
Asthma
5%
Bartonella quintana
5%
Child Health
5%
Clinical Feature
5%
Epstein-Barr Virus Infection
5%
Botulism
5%
Adverse Event
5%
Eosinophil
5%
Candidemia
5%
Virus Infection
5%
Congenital Toxoplasmosis
5%
Odontogenic Infection
5%
Jugular Vein
5%
Household
5%
Sepsis
5%
Herpes Simplex Virus
5%
Neonatal Sepsis
5%
Cat-Scratch Disease
5%
Health Care
5%
Neonatal Herpes Simplex
5%
Respiratory System Disease
5%
Sodium Chloride
5%
Heart Surgery
5%
Disseminated Herpes Zoster
5%
Endocarditis
5%
Spondylitis
5%
Intoxication
5%
Pediatrics Patient
5%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
20%
Bacterial Infection
16%
Vaccination Policy
14%
Infection
13%
Syndrome
13%
Adverse Event
11%
PFAPA Syndrome
10%
Clinical Feature
10%
Coronavirinae
10%
2009 H1N1 Influenza
9%
Wheezing
9%
Influenza A Virus (H1N1)
9%
Staphylococcus Aureus
7%
C Reactive Protein
7%
Disease Severity
6%
Cohort Study
6%
Oral Poliomyelitis Vaccine
5%
Acinetobacter Baumannii
5%
Bartonella quintana
5%
Sodium Chloride
5%
Procalcitonin
5%
Candidemia
5%
Tooth Infection
5%
Gastroenteritis
5%
Oseltamivir
5%
Poliomyelitis Vaccine
5%
Herpes Zoster
5%
Sepsis
5%
Herpes Simplex Virus
5%
Fatality
5%
Newborn Sepsis
5%
Injury
5%
Rotavirus
5%
Ibuprofen
5%
Symptom
5%
Congenital Toxoplasmosis
5%
Soft Tissue Infection
5%
Endocarditis
5%
Colchicine
5%
Bacterial Endocarditis
5%
Clindamycin
5%
Carbapenem
5%
Toxic Injury
5%
Bloodstream Infection
5%
Virus Infection
5%
